• 1
    Black CM, Stephens C: Systemic sclerosis (scleroderma) and related disorders. In, Oxford Textbook of Rheumatology. Edited by PJMaddison, DAIsenberg, PWoo, DNGlass. Oxford, Oxford University Press, 1993
  • 2
    Russell ML, Friesen D, Henderson RD, Hanna WM: Ultrastructure of the esophagus in scleroderma. Arthritis Rheum 25: 11171123, 1982
  • 3
    Silver RM: Clinical aspects of systemic sclerosis (scleroderma). Ann Rheum Dis 50 (suppl 4): 854861, 1991
  • 4
    Dessein PH, Joffe BI, Metz RM, Millar DL, Lawson M, Stanwix AE: Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. Am J Med 93: 143150, 1992
  • 5
    Cohen S, Laufer I, Snape WJ, Shiau YF, Levine GM, Jimenez S: The gastrointestinal manifestations of scleroderma: pathogenesis and management. Gastroenterology 79: 155166, 1980
  • 6
    Hostein J, Fournet J: Gastrointestinal manifestations of collagen diseases. Dig Dis 4: 240252, 1986
  • 7
    Akesson A, Wollheim FA: Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol 28: 281286, 1989
  • 8
    Sjogren RW: Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 37: 12651282, 1994
  • 9
    Hamel-Roy J, Devroede G, Arhan P, Tetreault L, Duranceau A, Menard H: Comparative esophageal and anorectal motility in scleroderma. Gastroenterology 88: 17, 1985
  • 10
    Bortolotti M, Turba E, Tosti A, Sarti P, Brunelli F, Campo LD, Barbara L: Gastric emptying and interdigestive antroduodenal motility in patients with esophageal scleroderma. Am J Gastroenterol 86: 922926, 1991
  • 11
    D'Angelo WA, Fries JF, Masi AT, Shulman LE: Pathologic observations in systemic sclerosis (scleroderma). Am J Med 46: 428440, 1969
  • 12
    Kemp-Harper RA, Jackson DC: Progressive systemic sclerosis. Br J Radiol 38: 825834, 1965
  • 13
    LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 15: 202205, 1988
  • 14
    Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23: 581590, 1980
  • 15
    Krieg T, Meurer M: Systemic scleroderma: clinical and pathophysiologic aspects. J Am Acad Dermatol 18: 457481, 1988
  • 16
    Bassotti G, Gaburri M, Imbimbo BP, Betti C, Daniotti S, Pelli MA, Morelli A: Manometric evaluation of cimetropium bromide activity in patients with the nutcracker oesophagus. Scand J Gastroenterol 23: 10791084, 1988
  • 17
    Bassotti G, Alunni G, Cocchieri M, Pelli MA, Morelli A: Isolated hypertensive lower esophageal sphincter: clinical and manometric aspects of an uncommon esophageal motor abnormality. J Clin Gastroenterol 14: 285287, 1992
  • 18
    Bassotti G, Pelli MA, Morelli A: Esophageal motor disorders in patients evaluated for dysphagia and/or noncardiac chest pain. Dysphagia 7: 37, 1992
  • 19
    Wiener GJ, Richter JE, Copper JB, Wu WC, Castell DO: The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 83: 358361, 1988
  • 20
    Usai P, Bassotti G, Usai Satta P, Cherchi MV, Plesa A, Boy F, Morelli A, Balestrieri A: Oesophageal motility in adult coeliac disease. Neurogastroenterol Motil 7: 239244, 1995
  • 21
    Bassotti G, Gullà P, Betti C, Whitehead WE, Morelli A: Manometric evaluation of the jejunal limb after total gastrectomy and Roux-Orr anastomosis for gastric cancer. Br J Surg 77: 10251029, 1990
  • 22
    Bassotti G, Castellucci G, Betti C, Fusaro C, Cavalletti ML, Bertotto A, Spinozzi F, Morelli A, Pelli MA: Abnormal gastrointestinal motility in patients with celiac sprue. Dig Dis Sci 39: 19471954, 1994
  • 23
    Bassotti G, Bucaneve G, Betti C, Patoia L, Baratta E, Maresca V, Pelli MA, Morelli A, Del Favero A: Effects of parenteral diclofenae sodium on upper gastrointestinal motility after food in man. Eur J Clin Pharmacol 41: 497500, 1991
  • 24
    Ollyo JB, Lang F, Fontolliet C, Monnier P: Savary-Miller's new endoscopic grading of reflux-oesophagitis: a simple, reproducible, logical, complete and useful classification (abstract). Gastroenterology 98 (suppl): A100, 1990
  • 25
    Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M. Savarino V, DiMario F, Battaglia G, Mela GS, Pilotto A, Plebani M, Davi G: A comparison of five mainteinance therapies for reflux esophagitis. N Engl J Med 333: 11061110, 1995
  • 26
    Bassotti G, Bacci G, Biagini D, David P, Alunni G, Pelli MA, Morelli A: Manometric evaluation of the entire esophagus in healthy subjects and patients with high-amplitude peristaltic contractions. Dysphagia 3: 9396, 1988
  • 27
    Traube M, Albibi R, McCallum RW: High-amplitude peristaltic esophageal contractions associated with chest pain. JAMA 250: 26552659, 1983
  • 28
    Castell JA: The computer in the motility laboratory. In, Esophageal Motility Testing. Edited by DOCastell, JERichter, CBDalton. New York, Elsevier Science Publishing Co., 1987
  • 29
    Clouse RE, Staiano A: Contraction abnormalities of the esophageal body in patients referred for manometry: a new approach to classfication. Dig Dis Sci 28: 784791, 1983
  • 30
    Richter JE: Normal values for esophageal manometry. In, Esophageal Motility Testing. Edited by DOCastell, JERichter, CBDalton. New York. Elsevier Science Publishing. 1987
  • 31
    DeMeester TR, Johnson LF, Joseph GJ, Toscano MS, Hall AW, Skinner DB: Patterns of gastroesophageal reflux in health and disease. Ann Surg 184: 459470, 1976
  • 32
    Vantrappen G, Janssens J, Hellemans J. Ghoos Y: The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 59: 11581166, 1977
  • 33
    Kerlin P, Phillips S: Variability of motility of the ileum and jejunum in healthy humans. Gastroenterology 82: 694700, 1982
  • 34
    Wingate DL: Small bowel manometry. Am J Gastroenterol 90: 536539, 1995
  • 35
    Stanghellini V, Camilleri M. Malagelada JR: Chronic idiopathic intestinal pseudoobstruction: clinical and intestinal manometric findings. Gut 28: 512, 1987
  • 36
    Camilleri M: Appraisal of medium- and long-term treatment of gastroparesis and chronic intestinal dysmotility. Am J Gastroenterol 89: 17691774, 1994
  • 37
    STATGRAPHICS®: Statitical Graphics System by Statistical Graphics Corporation. Rockville, MD, 1986
  • 38
    Kallenberg CGM, Wouda AA, Hoet MH, van Venrooij WJ: Development of connective tissue disease in patients presenting with Raynaud phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 47: 634641, 1988
  • 39
    Klein HA, Wald A, Graham TO, Campbell WL, Steen VD: Comparative studies of esophageal function in systemic sclerosis. Gastroenterology 102: 15511556, 1992
  • 40
    Murphy JR, McNally P, Peller P, Shy SS: Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis. Dig Dis Sci 37: 833841, 1992
  • 41
    Dantas RO. Meneghelli UG, Oliveira RB, Villanova MG: Esophageal dysfunction does not always worsen in systemic sclerosis. J Clin Gastroenterol 17: 281285, 1993
  • 42
    Yarze JC, Varga J, Stampfl D, Castell DO, Jimienez SA: Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol 88: 870876, 1993
  • 43
    Wegener M, Adamek RJ, Wedmann B, Jergas M, Almeyer P: Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 39: 22092215, 1994
  • 44
    Zamost BJ, Hirschberg J, Ippoliti AF, Furst DE, Clements PJ, Weinstein WM: Esophagitis in scleroderma: prevalence and risk factors. Gastroenterology 92: 421428, 1987
  • 45
    Aubert A, Lazareth I, Vayssairat M. Fiessinger JN, Petite JP: L'oesophagite au course de la sclerodermie systemique: prevalence et facteurs de survenue chez 46 patients. Gastroenterol Clin Biol 15: 945949, 1991
  • 46
    Creamer B, Anderson HA, Code CF: Esophageal motility in patients with scleroderma and related diseases. Gastroenterologia (Basel) 86: 763775, 1956
  • 47
    Atkinson M, Summerhing MD: Oesophageal changes in systemic sclerosis Gut 7: 402408, 1966
  • 48
    Cohen S, Fisher R, Lipshutz W. Turner R, Myers A, Schumacher HR: The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease. J Clin Invest 51: 26632668, 1972
  • 49
    Schneider HA, Yonker RA, Longley S, Katz P, Mathias J, Panush RS: Scleroderma esophagus: a nonspecific entity. Ann Intern Med 100: 848850, 1984
  • 50
    Tsianos EB, Drosos AA, Chiras CD, Moutsopoulos HM, Kitridou RC: Esophageal manometric findings in autoimmune rheumatic disease is scleroderma esophagus a specific identity? Rheumatol Int 7: 2327, 1987
  • 51
    Bassotti G. Giaburri M. Biscarini L, Baratta E, Pelli MA, Del Favero A, Morelli A: Oesophageal motor activity in rheumatoid arthritis: a clinical and manometric study. Digestion 39: 144150, 1988
  • 52
    Helms JF, Dodds WJ, Pelc WR, Palmer DW, Hogan WJ: Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med 310: 284288, 1984
  • 53
    Marlett JA, Code CF: Effects of celiac and superior mesenteric ganglionectomy on interdigestive myoelectric complex in dogs. Am J Physiol 237: E432E436, 1979
  • 54
    Camilleri M, Malagelada JR: Abnormal intestinal motility in diabetics with gastroparesis syndrome. Eur J Clin Invest 14: 420427, 1984
  • 55
    Pfaffenbach B, Adamek RJ, Hagemann D, Busch S, Hoffmann K, Almeyer P, Schaffstein J, Wegener M: Effect of progressive systemic sclerosis on antral myoelectrical activity and gastric emptying. Z Gastroenterol 34: 517521, 1996
  • 56
    DiMarino AJ, Carlson G, Myers A, Schumacher HR, Cohen S: Duodenal myoelectric activity in scleroderma: abnormal responses to mechanical and hormonal stimuli. N Engl J Med 289: 12201223, 1973
  • 57
    Horowitz M, Maddern GJ, Maddox A, Wishart J, Chatterton BE, Shearman DJ: Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis. Gastroenterology 93: 311315, 1987
  • 58
    Soudah HC, Hasler WL, Owyang C: Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 325: 14611467, 1991
  • 59
    Verne GN, Eaker EY, Hardy E, Sninsky CA: Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Dig Dis Sci 40: 18921901, 1995
  • 60
    Kaye SA, Siraj QH, Agnew J, Hilson A, Black CM: Detection of early asymptomatic esophageal dysfunction in systemic sclerosis using a new scintigraphic grading method. J Rheumatol 23: 297301, 1996
  • 61
    Kahan A, Bour B, Couturier D, Amor B, Menkes CJ: Nifedipine and esophageal dysfunction in progressive systemic sclerosis: a controlled manometric study. Arthritis Rheum 28: 490495, 1985